5,0
18 set 2017
Dipendente attuale, meno di un anno
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
2017 is a great time for IMRIS. The company is moving forward with a lot of initiatives and they are hiring the right people to help the company go from a good Med Tech company to an INCREDIBLE Med Tech company!
Svantaggi
I would have to say the only con is that the company had some negative financial dealings a few years back, but they have recovered from those 100 fold!